LEADING THE WAY TOWARD A MALARIA-FREE WORLD.
In Africa, malaria is devastating. It’s the number three killer of children. It’s also chronic, affecting more than 200 million people each year and imposing an immense economic burden on families and countries.
PATH is leading the way toward a malaria-free world by focusing on vaccines, new treatments and diagnostic tools, and the rapid elimination of malaria in key countries. With your support, we will develop the next generation of tools and approaches to break the cycle of malaria transmission, dramatically reducing childhood and maternal illness and death.
WHAT YOU NEED TO KNOW
- Malaria affects more than 200 million people each year and kills more than 400,000.
- Malaria is the number three killer of children worldwide.
- 3.3 billion people—half the world’s population—are at risk for malaria every year.
- Malaria accounts for up to 40 percent of total spending on public health in Africa and costs African economies more than US$12 billion per year.
- Since 2000, the number of new cases of malaria has declined by 37 percent globally, and deaths from malaria have fallen by 60 percent, saving an estimated 6.2 million lives—largely as a result of simple disease-control strategies.
- Pushing toward eradication—rather than simply control—will save approximately 5 billion lives per year.
- May 2016: The number of children with malaria in Zambia's Southern Province dropped 93 percent after implementing our innovative approach to tackling the disease.
- January 2016: The World Health Organization recommended the RTS,S malaria vaccine candidate, which PATH helped develop, for a pilot program in Africa.
- July 2015: With an endorsement from European regulators, the world's most advanced malaria vaccine candidate, RTS,S, moved closer to use.
- August 2014–March 2015: About 39 million malaria treatments with semisynthetic artemisinin shipped to 23 countries.
Photo: PATH/Gabe Bienczycki